课题基金 / 基金详情

Molecular design of anti-AIDS drugs targeting the human transcription machinery employed for the replication of AIDS virus

Molecular design of anti-AIDS drugs targeting the human transcription machinery employed for the replication of AIDS virus
针对艾滋病病毒复制所用的人类转录机制的抗艾滋病药物的分子设计
批准号:
12557219
负责人:
OTSUKA Masami
金额:
$7.49万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2002

项目摘要

项目成果

OTSUKA Masami的其他基金

相似基金

相关文献

中文摘要
翻译
艾滋病前病毒的启动子区长末端重复序列包含一个串联的kB序列、三个连续的GC盒和一个TATA盒。NFkB、HIV-EP 1和Sp1蛋白与这些序列特异性结合,参与AIDS病毒的转录和复制。目前的研究针对蛋白质和核酸,即。例如,抑制这些转录蛋白的功能和设计靶向长末端重复序列Sp1和HIV-EP 1的DNA切割剂是在其DNA切割结合位点含有锌的锌指蛋白。我们制备了各种基于吡啶的锌螯合剂,通过提取锌来灭活这些蛋白质。考虑到酶的结合作用,我们合成了吡啶上带有芳香取代基的联苯型金属螯合剂。特别地,具有萘基的化合物对锌蛋白表现出优异的抑制活性。我们进行了一种新的肽核酸的分子设计,用于特异性识别HIV前病毒的DNA序列。我们制备了以D-和L-天冬氨酸为起始原料的含有甘氨酰-b-丙氨酸骨架的肽核酸的光学活性单体组分和相应的寡聚体,因此,本研究的结果包括成功设计了抑制锌蛋白功能的新型金属螯合剂和开发了能够靶向AIDS前病毒DNA的新型肽核酸。
英文摘要
The Long Terminal Repeat, the promoter region of the AIDS provirus contains a tandem kB sequence, three consecutive GC boxes, and a TATA box. Proteins NFkB, HIV-EP1 and Sp1 specifically bind to these sequences and paticipate in the transcription amf replicatiom of AIDS virus. The present research aimed at proteins and nucleic acids, i. e., the inhibition of the functions of these transcriptional proteins and the design of DNA-cleaving agents targeting the Long Terminal RepeatSp1 and HIV-EP1 is a zinc finger proteins containing zinc in their DNA recognition-binding sites. We prepared various pyridine-based zinc chelators to inactivate these proteims by abstracting zinc. We synthesized biphenyl-type metal chelators with an aromatic substituent on the pyridine, considering the enzyme binding. In particular, a compound with a naphthyl group showed excellent inhibitory activity against a zinc protein.We carried out a molecular design of novel peptide nucleic acid for the specific recognition of the DNA sequence of HIV provirus. We prepared optically active monomer constituents and the corresponding oligomer of peptide nucleic acids containing a glycyl-b-alanine backbone starting with D-and L-aspartic acids.Thus, the results of the present research include the successful design of novel metal chelators that inhibit the function of zinc proteins and development of a novel peptide nucleic acid that could target the DNA of AIDS provirus.
期刊论文(42)
专著(0)
科研奖励(0)
会议论文
Rakesh Kumar Sharma: "Aurine tricarboxylic acid, a potential metal-chelating inhibitor of NFkB-DNA binding"Bioorg.Med.Chem.. 8. 1819-1823 (2000)
Rakesh Kumar Sharma:“金三羧酸,NFkB-DNA 结合的潜在金属螯合抑制剂”Bioorg.Med.Chem.. 8. 1819-1823 (2000)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hitoshi Takatsuna: "Identification of TIFA as an Adapter Protein that Links TRAP6 to IRAK-1 in IL-1 Receptor Signaling"J. Bio. Chem.. in press (2003)
Hitoshi Takatsuna:“鉴定 TIFA 作为 IL-1 受体信号传导中将 TRAP6 与 IRAK-1 连接的衔接蛋白”J。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Akiyuki Hamasaki: "A Novel Metal-Chelating Inhibitor of Protein Farnesytransferase"Bioorg. Med. Chem. Lett.. in press (2003)
Akiyuki Hamasaki:“蛋白质法尼基转移酶的新型金属螯合抑制剂”Bioorg。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
20
    Design and synthesis of anti-brain tumor and brain-protective drugs using brain-targeting peptides
    • 批准号:
      24659048
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2012
    • 负责人:
      OTSUKA Masami
    • 依托单位:
    Development of medicinal molecules having biologically functions targeting the PI3K/Akt pathway and the TGF-b/Smad pathway
    • 批准号:
      23390028
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.56万
    • 财政年份:
      2011
    • 负责人:
      OTSUKA Masami
    • 依托单位:
    Design and synthesis of anti-HIV agents that inhibit the Vif-mediated proteasome degradation of APOBEC3G
    • 批准号:
      22659024
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $1.89万
    • 财政年份:
      2010
    • 负责人:
      OTSUKA Masami
    • 依托单位:
    Design of DNA-cleaving and -crosslinking agents based on NFκB and HMGA proteins aiming at the application to cancer therapy
    • 批准号:
      20390033
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.15万
    • 财政年份:
      2008
    • 负责人:
      OTSUKA Masami
    • 依托单位:
    海外基金